课题基金 / 基金详情

NIAID-VRC-Research, Development, and Production to Support Ebola Bispecific Antibody Development

NIAID-VRC-Research, Development, and Production to Support Ebola Bispecific Antibody Development
NIAID-VRC-支持埃博拉双特异性抗体开发的研究、开发和生产
批准号：
10722435
负责人：
CHRIS CASE
金额：
$276.5万
依托单位：
LEIDOS BIOMEDICAL RESEARCH, INC.
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
项目状态：
未结题
起止时间：
2022-09-19 至 2027-09-18
来源：
https://reporter.nih.gov/project-details/10722435
关键词：
Bispecific AntibodiesClinicalCommunicable DiseasesDevelopmentDisease OutbreaksEbolaFutureLeadMissionNational Institute of Allergy and Infectious DiseasePreventionProcessProductionReagentTechnology TransferTherapeuticpandemic diseaseproduct developmentresearch and developmentvaccine developmentvaccine-induced antibodies

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The NIAID mission and scope includes rapidly responding to infectious disease outbreaks and preparing for future pandemics through clinical product development, reagent production, and manufacturing. In following this mission, the VRC has prioritized development of vaccines and antibodies targeting Ebola that may lead to prevention and/or therapeutic treatment. Specifically, the VRC seeks to develop and manufacture Ebola bispecific antibody products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data